BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 33522123)

  • 1. Calixarene-Embedded Nanoparticles for Interference-Free Gene-Drug Combination Cancer Therapy.
    Liu Q; Zhang TX; Zheng Y; Wang C; Kang Z; Zhao Y; Chai J; Li HB; Guo DS; Liu Y; Shi L
    Small; 2021 Feb; 17(8):e2006223. PubMed ID: 33522123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calixarene-modified albumin for stoichiometric delivery of multiple drugs in combination-chemotherapy.
    Wang Y; Zhang Z; Zhao X; Xu L; Zheng Y; Li HB; Guo DS; Shi L; Liu Y
    Theranostics; 2022; 12(8):3747-3757. PubMed ID: 35664058
    [No Abstract]   [Full Text] [Related]  

  • 3. Active targeting tumor therapy using host-guest drug delivery system based on biotin functionalized azocalix[4]arene.
    Chen MM; Tang X; Li JJ; Chen FY; Jiang ZT; Fu R; Li HB; Hu XY; Geng WC; Guo DS
    J Control Release; 2024 Apr; 368():691-702. PubMed ID: 38492860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engineering blood exosomes for tumor-targeting efficient gene/chemo combination therapy.
    Zhan Q; Yi K; Qi H; Li S; Li X; Wang Q; Wang Y; Liu C; Qiu M; Yuan X; Zhao J; Hou X; Kang C
    Theranostics; 2020; 10(17):7889-7905. PubMed ID: 32685027
    [No Abstract]   [Full Text] [Related]  

  • 5. Calixarene: A Versatile Material for Drug Design and Applications.
    Hussain MA; Ashraf MU; Muhammad G; Tahir MN; Bukhari SNA
    Curr Pharm Des; 2017; 23(16):2377-2388. PubMed ID: 27779081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alternating block copolymer-based nanoparticles as tools to modulate the loading of multiple chemotherapeutics and imaging probes.
    Mattu C; Brachi G; Menichetti L; Flori A; Armanetti P; Ranzato E; Martinotti S; Nizzero S; Ferrari M; Ciardelli G
    Acta Biomater; 2018 Oct; 80():341-351. PubMed ID: 30236799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Azocalix[4]arene-Rhodamine Supramolecular Hypoxia-Sensitive Systems: A Search for the Best Calixarene Hosts and Rhodamine Guests.
    Mironova D; Burilov V; Galieva F; Khalifa MAM; Kleshnina S; Gazalieva A; Nugmanov R; Solovieva S; Antipin I
    Molecules; 2021 Sep; 26(18):. PubMed ID: 34576922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of Calixarene in Chemotherapy Delivery Strategies.
    Basilotta R; Mannino D; Filippone A; Casili G; Prestifilippo A; Colarossi L; Raciti G; Esposito E; Campolo M
    Molecules; 2021 Jun; 26(13):. PubMed ID: 34209495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Supramolecular Radiosensitizer Based on Hypoxia-Responsive Macrocycle.
    Hou X; Chang YX; Yue YX; Wang ZH; Ding F; Li ZH; Li HB; Xu Y; Kong X; Huang F; Guo DS; Liu J
    Adv Sci (Weinh); 2022 Feb; 9(6):e2104349. PubMed ID: 34994113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enzyme and Thermal Dual Responsive Amphiphilic Polymer Core-Shell Nanoparticle for Doxorubicin Delivery to Cancer Cells.
    Kashyap S; Singh N; Surnar B; Jayakannan M
    Biomacromolecules; 2016 Jan; 17(1):384-98. PubMed ID: 26652038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ATRP Fabricated and Short Chain Polyethylenimine Grafted Redox Sensitive Polymeric Nanoparticles for Codelivery of Anticancer Drug and siRNA in Cancer Therapy.
    Nehate C; Moothedathu Raynold AA; Koul V
    ACS Appl Mater Interfaces; 2017 Nov; 9(45):39672-39687. PubMed ID: 29048878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Calixarene-dependent hydrolysis of ATP. I. Kinetics and complexation of the calixarene C-107 with nucleoside triphosphate].
    Shkrabak OA; Kal'chenko OI; Rodik RV; Veklich TO; Kal'chenko VI; Kosterin SO
    Ukr Biokhim Zh (1999); 2008; 80(2):90-100. PubMed ID: 18819379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calixarene: A Supramolecular Material for Treating Cancer.
    Li R; Liu N; Liu R; Jin X; Li Z
    Curr Drug Deliv; 2024; 21(2):184-192. PubMed ID: 37073159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A supramolecular nanoparticle system based on β-cyclodextrin-conjugated poly-l-lysine and hyaluronic acid for co-delivery of gene and chemotherapy agent targeting hepatocellular carcinoma.
    Xiong Q; Cui M; Bai Y; Liu Y; Liu D; Song T
    Colloids Surf B Biointerfaces; 2017 Jul; 155():93-103. PubMed ID: 28411478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calixarene assembly with enhanced photocurrents using P(SNS-NH2)/CdS nanoparticle structure modified Au electrode systems.
    Sayin S; Azak H; Yildiz HB; Camurlu P; Akkus GU; Toppare L; Ersoz M
    Phys Chem Chem Phys; 2015 Aug; 17(30):19911-8. PubMed ID: 26166614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. pH-sensitive polymeric nanoparticles for co-delivery of doxorubicin and curcumin to treat cancer via enhanced pro-apoptotic and anti-angiogenic activities.
    Zhang J; Li J; Shi Z; Yang Y; Xie X; Lee SM; Wang Y; Leong KW; Chen M
    Acta Biomater; 2017 Aug; 58():349-364. PubMed ID: 28455219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic breast tumor cell killing achieved by intracellular co-delivery of doxorubicin and disulfiram via core-shell-corona nanoparticles.
    Tao X; Gou J; Zhang Q; Tan X; Ren T; Yao Q; Tian B; Kou L; Zhang L; Tang X
    Biomater Sci; 2018 Jun; 6(7):1869-1881. PubMed ID: 29808221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-Delivery of Doxorubicin and Survivin shRNA-Expressing Plasmid Via Microenvironment-Responsive Dendritic Mesoporous Silica Nanoparticles for Synergistic Cancer Therapy.
    Li Z; Zhang L; Tang C; Yin C
    Pharm Res; 2017 Dec; 34(12):2829-2841. PubMed ID: 28948461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-101 and doxorubicin codelivered by liposomes suppressing malignant properties of hepatocellular carcinoma.
    Xu F; Liao JZ; Xiang GY; Zhao PX; Ye F; Zhao Q; He XX
    Cancer Med; 2017 Mar; 6(3):651-661. PubMed ID: 28135055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced anti-tumor efficacy by co-delivery of doxorubicin and paclitaxel with amphiphilic methoxy PEG-PLGA copolymer nanoparticles.
    Wang H; Zhao Y; Wu Y; Hu YL; Nan K; Nie G; Chen H
    Biomaterials; 2011 Nov; 32(32):8281-90. PubMed ID: 21807411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.